Colorectal Cancer News and reporting on colorectal cancer. Sep 13, 2022 Nearly all dMMR Colon Cancer Patients Respond in Trial of Neoadjuvant Opdivo-Yervoy Premium Sep 7, 2022 Isofol Medical Halts Colon Cancer Study After Negative Readout; Continues Subgroup Analyses Sep 2, 2022 Owkin Digital Pathology Algorithms for Colorectal, Breast Cancer Receive CE Mark Aug 29, 2022 Genetic Testing Challenges in Oncology: Lynch Syndrome Diagnosis Despite Negative Test Results Aug 23, 2022 Erasca, MD Anderson Cancer Center Partner to Study ERK, SHP2 Inhibitors Aug 22, 2022 Emtora Nets $16.9M Grant to Advance Drug for Genetic Condition That Increases Colon Cancer Risk Aug 22, 2022 Pillar Biosciences Receives China Approval for Colon Cancer Companion Diagnostic Assay Aug 18, 2022 Innovative Cellular Therapies Begins Trial of Autologous CAR T-Cell Therapy in Colorectal Cancer Aug 8, 2022 CAP Weighs in on dMMR, MSI Assays for Immunotherapy Patient Selection Premium Aug 2, 2022 Guardant Health Receives Medicare Coverage for MRD Liquid Biopsy in Stage II and III Colon Cancer Jul 29, 2022 Sotio Biotech Begins Phase II Trial of IL-15-Targeted Candidate in Solid Tumors Jul 28, 2022 Aniling Gets CE-IVD Marks for Cancer Sequencing Tests Jul 1, 2022 Treos Bio, Roche Begin Combination Immunotherapy Study in Microsatellite-Stable Colorectal Cancer Jun 30, 2022 Faeth Therapeutics Closes $47M Series A Round to Explore Precision Diet Cancer Therapy Benefits Jun 28, 2022 Revolution Medicines Begins Phase I/Ib Trial in KRAS G12-Mutant Tumors Jun 23, 2022 Drugmakers Going After RAS, MAPK Pathway to Tackle Cancers With Variety of KRAS Mutations Premium Jun 21, 2022 Exelixis Launches Phase III Trial of XL092 in Certain Colorectal Cancer Patients Jun 7, 2022 Circulating Tumor DNA Utility in Post-Surgery Stage II Colon Cancer Cemented by New Data Premium Jun 6, 2022 Vectibix Outperforms Avastin in First-Line RAS-Wildtype Left-Sided Colorectal Cancer Premium Jun 5, 2022 Rectal Cancer Patient Subset Shows Complete Response to Immunotherapy in Small Study Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
